Sign up today and save up to 67% on a Hartford Courant digital subscription

Massachusetts General Hospital

Study casts doubt on computer-aided mammograms

Hologic and Icad, makers of medical imaging equipment, fell in New York trading after a study found that breast cancer screening performed with computer-aided technology failed to find more tumors. The technology, approved in the U.S. in 1998, is used in 90 percent of mammograms performed each year at a cost of more than $400 million, according to lead researcher Constance Lehman, director of breast imaging and co-director of the Avon Foundation Comprehensive Breast Evaluation Center at Massachusetts General Hospital in Boston. That should end, she said. "There is absolutely no question from our research that computer-aided detection offers no benefit to catching cancers that...